Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Clinical protocols"" wg kryterium: Temat


Tytuł:
Gut dysbiosis is linked to metabolic syndrome in obese Egyptian women: potential treatment by probiotics and high fiber diets regimen.
Autorzy:
Hassan NE; Biological Anthropology Department, Medical Research and Clinical Studies Institute, National Research Centre, 33 El-Buhouth St., Dokki, Giza, 12622, Egypt.
El-Masry SA; Biological Anthropology Department, Medical Research and Clinical Studies Institute, National Research Centre, 33 El-Buhouth St., Dokki, Giza, 12622, Egypt. .
El Shebini SM; Nutrition and Food Science Department, Food and Industries and Nutrition Research Institute, National Research Centre, Giza, Egypt.
Ahmed NH; Nutrition and Food Science Department, Food and Industries and Nutrition Research Institute, National Research Centre, Giza, Egypt.
Mohamed T F; Food and Dairy Microbiology Department, Food and Industries and Nutrition Research Institute, National Research Centre, Giza, Egypt.
Mostafa MI; Clinical Pathology Department, Medical Research and Clinical Studies Institute, National Research Centre, Giza, Egypt.
Afify MAS; Biological Anthropology Department, Medical Research and Clinical Studies Institute, National Research Centre, 33 El-Buhouth St., Dokki, Giza, 12622, Egypt.
Kamal AN; Biological Anthropology Department, Medical Research and Clinical Studies Institute, National Research Centre, 33 El-Buhouth St., Dokki, Giza, 12622, Egypt.
Badie MM; Biological Anthropology Department, Medical Research and Clinical Studies Institute, National Research Centre, 33 El-Buhouth St., Dokki, Giza, 12622, Egypt.
Hashish A; Children With Special Needs Department, Medical Research and Clinical Studies Institute, National Research Centre, Giza, Egypt.
Alian K; Biological Anthropology Department, Medical Research and Clinical Studies Institute, National Research Centre, 33 El-Buhouth St., Dokki, Giza, 12622, Egypt.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Mar 05; Vol. 14 (1), pp. 5464. Date of Electronic Publication: 2024 Mar 05.
Typ publikacji:
Journal Article
MeSH Terms:
Metabolic Syndrome*/therapy
Female ; Humans ; Adult ; Middle Aged ; Dysbiosis/therapy ; Egypt ; Clinical Protocols ; Obesity/complications ; Obesity/therapy ; Bacteroidetes ; Firmicutes
Czasopismo naukowe
Tytuł:
Benefits of a dermocosmetic regimen in the management of local side effects triggered by a topical retinoid-based acne treatment.
Autorzy:
Karamon E; Studio Dermatologia i Kosmetyka, Malbork, Poland.
Czermańska A; Eurofins-Dermscan, Gdańsk, Poland.
Kerob D; International Scientific Direction, La Roche-Posay Laboratoire Dermatologique, Levallois-Perret, France.
Demessant AL; International Scientific Direction, La Roche-Posay Laboratoire Dermatologique, Levallois-Perret, France.
Le Dantec G; International Scientific Direction, La Roche-Posay Laboratoire Dermatologique, Levallois-Perret, France.
le Floc'h C; International Scientific Direction, La Roche-Posay Laboratoire Dermatologique, Levallois-Perret, France.
Tan J; Department of Medicine and Windsor Clinical Research Inc, Western University, Windsor, Ontario, Canada.
Pokaż więcej
Źródło:
Journal of cosmetic dermatology [J Cosmet Dermatol] 2024 Mar; Vol. 23 (3), pp. 1091-1093. Date of Electronic Publication: 2023 Nov 20.
Typ publikacji:
Letter
MeSH Terms:
Retinoids*/therapeutic use
Acne Vulgaris*/drug therapy
Humans ; Administration, Topical ; Clinical Protocols
Opinia redakcyjna
Tytuł:
Simplified treatment protocols improve recovery of children with severe acute malnutrition in South Sudan: results from a mixed methods study.
Autorzy:
Lyles E; Johns Hopkins Bloomberg School of Public Health, 615 N Wolfe St, Suite E8132, Baltimore, MD, 21205, USA.
Ismail S; Integral Global Consulting, Atlanta, GA, USA.; US Centers for Disease Control and Prevention, Atlanta, GA, USA.
Ramaswamy M; US Centers for Disease Control and Prevention, Atlanta, GA, USA.
Drame A; US Centers for Disease Control and Prevention, Atlanta, GA, USA.
Leidman E; US Centers for Disease Control and Prevention, Atlanta, GA, USA.
Doocy S; Johns Hopkins Bloomberg School of Public Health, 615 N Wolfe St, Suite E8132, Baltimore, MD, 21205, USA. .
Pokaż więcej
Źródło:
Journal of health, population, and nutrition [J Health Popul Nutr] 2024 Feb 02; Vol. 43 (1), pp. 21. Date of Electronic Publication: 2024 Feb 02.
Typ publikacji:
Journal Article
MeSH Terms:
Severe Acute Malnutrition*/therapy
COVID-19*
Malnutrition*/therapy
Child ; Humans ; Infant ; South Sudan ; Nutritional Status ; Clinical Protocols
Czasopismo naukowe
Tytuł:
Efficacy of a 2-week therapy with levofloxacin concomitant versus a levofloxacin sequential regimen for Helicobacter pylori infection in the Syrian population: a study protocol for randomized controlled trial.
Autorzy:
Alhalabi M; Gastroenterology Department, Damascus Hospital, Almujtahed Street, Damascus, Syria. .
Almokdad R; Gastroenterology Department, Damascus Hospital, Almujtahed Street, Damascus, Syria.
Pokaż więcej
Źródło:
Trials [Trials] 2024 Jan 15; Vol. 25 (1), pp. 55. Date of Electronic Publication: 2024 Jan 15.
Typ publikacji:
Clinical Trial Protocol; Journal Article
MeSH Terms:
Helicobacter Infections*/diagnosis
Helicobacter Infections*/drug therapy
Helicobacter pylori*
Adolescent ; Adult ; Aged ; Female ; Humans ; Male ; Middle Aged ; Young Adult ; Anti-Bacterial Agents/adverse effects ; Clinical Protocols ; Drug Therapy, Combination ; Levofloxacin/adverse effects ; Metronidazole ; Prospective Studies ; Proton Pump Inhibitors/therapeutic use ; Randomized Controlled Trials as Topic ; Syria ; Treatment Outcome ; Equivalence Trials as Topic
Czasopismo naukowe
Tytuł:
Global adoption of 6-month drug-resistant TB regimens: Projected uptake by 2026.
Autorzy:
Gupta A; TB Alliance, New York, NY, United States of America.
Juneja S; TB Alliance, New York, NY, United States of America.
Babawale V; National Tuberculosis and Leprosy Control Programme, Abuja, Nigeria.
Rustam Majidovich N; National TB Programme, Dushanbe, Tajikistan.
Ndjeka N; National Department of Health, Pretoria, South Africa.
Thi Mai Nguyen P; National Tuberculosis Programme, Hanoi, Vietnam.
Nargiza Nusratovna P; National TB Programme, Tashkent, Uzbekistan.
Robert Omanito D; Disease Prevention and Control Bureau, Philippine Department of Health, Manila, Philippines.
Tiara Pakasi T; National Tuberculosis Programme, Ministry of Health, Jakarta, Indonesia.
Terleeva Y; National Tuberculosis Programme, Kyiv, Ukraine.
Toktogonova A; National TB Centre, Bishkek, Kyrgyzstan.
Waheed Y; National TB Control Programme, Islamabad, Pakistan.
Myint Z; National TB Programme, Naypyidaw, Myanmar.
Yanlin Z; National Center for TB Control and Prevention, National Tuberculosis Reference Laboratory of China, Chinese Center for Disease Control and Prevention, Beijing, China.
Sahu S; Stop TB Partnership, Geneva, Switzerland.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Jan 05; Vol. 19 (1), pp. e0296448. Date of Electronic Publication: 2024 Jan 05 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Tuberculosis, Multidrug-Resistant*/drug therapy
Humans ; Linezolid ; Clinical Protocols ; Biological Transport
Czasopismo naukowe
Tytuł:
Impact of maternal first trimester treatment regimen on the outcome of valproate exposed pregnancies: an observational Embryotox cohort study.
Autorzy:
Fietz AK; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Clinical Pharmacology and Toxicology, Embryotox Center of Clinical Teratology and Drug Safety in Pregnancy, Augustenburger Platz 1, 13353, Berlin, Germany. .; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Biometry and Clinical Epidemiology, Charitéplatz 1, Berlin, Germany. .
Onken M; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Clinical Pharmacology and Toxicology, Embryotox Center of Clinical Teratology and Drug Safety in Pregnancy, Augustenburger Platz 1, 13353, Berlin, Germany.
Padberg S; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Clinical Pharmacology and Toxicology, Embryotox Center of Clinical Teratology and Drug Safety in Pregnancy, Augustenburger Platz 1, 13353, Berlin, Germany.
Schaefer C; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Clinical Pharmacology and Toxicology, Embryotox Center of Clinical Teratology and Drug Safety in Pregnancy, Augustenburger Platz 1, 13353, Berlin, Germany.
Dathe K; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Clinical Pharmacology and Toxicology, Embryotox Center of Clinical Teratology and Drug Safety in Pregnancy, Augustenburger Platz 1, 13353, Berlin, Germany.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Jan 05; Vol. 14 (1), pp. 674. Date of Electronic Publication: 2024 Jan 05.
Typ publikacji:
Observational Study; Journal Article
MeSH Terms:
Valproic Acid*/adverse effects
Abortion, Spontaneous*/chemically induced
Abortion, Spontaneous*/epidemiology
Female ; Pregnancy ; Male ; Humans ; Cohort Studies ; Pregnancy Trimester, First ; Clinical Protocols ; Anticonvulsants/adverse effects
Czasopismo naukowe
Tytuł:
A real-world study of the effectiveness and safety of apatinib-based regimens in metastatic triple-negative breast cancer.
Autorzy:
Huang W; Department of Medical Oncology, Fujian Medical University Union Hospital, No.29, Xinquan Road, Gulou District, Fuzhou, Fujian province, 350001, China.; Department of Medical Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, No.91, Fuma Road, Jin'an District, Fuzhou, Fujian province, 350014, China.; Fujian Key Laboratory of Translational Cancer Medicine, Fujian Cancer Hospotial, No.91, Fuma Road, Jin'an District, Fuzhou, Fujian province, 350014, China.
Wang C; Fujian Key Laboratory of Innate Immune Biology, Biomedical Research Center of South China, Fujian Normal University Qishan Campus, College Town, Fuzhou, Fujian Province, 350117, PR China.
Shen Y; Fujian Key Laboratory of Innate Immune Biology, Biomedical Research Center of South China, Fujian Normal University Qishan Campus, College Town, Fuzhou, Fujian Province, 350117, PR China.
Chen Q; Fujian Key Laboratory of Innate Immune Biology, Biomedical Research Center of South China, Fujian Normal University Qishan Campus, College Town, Fuzhou, Fujian Province, 350117, PR China.
Huang Z; Department of Breast Surgical Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, No. 91, Fuma Road, Jin'an District, Fuzhou, Fujian province, 350014, China.
Liu J; Department of Medical Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, No.91, Fuma Road, Jin'an District, Fuzhou, Fujian province, 350014, China.
Lin X; Department of Medical Oncology, Fujian Medical University Union Hospital, No.29, Xinquan Road, Gulou District, Fuzhou, Fujian province, 350001, China. .; Fujian Key Laboratory of Translational Cancer Medicine, Fujian Cancer Hospotial, No.91, Fuma Road, Jin'an District, Fuzhou, Fujian province, 350014, China. .
Wang L; Department of Medical Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, No.91, Fuma Road, Jin'an District, Fuzhou, Fujian province, 350014, China.
Wu F; Department of Medical Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, No.91, Fuma Road, Jin'an District, Fuzhou, Fujian province, 350014, China.
Chen X; Department of Medical Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, No.91, Fuma Road, Jin'an District, Fuzhou, Fujian province, 350014, China.
Li N; Department of Medical Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, No.91, Fuma Road, Jin'an District, Fuzhou, Fujian province, 350014, China.
Hong Y; Department of Medical Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, No.91, Fuma Road, Jin'an District, Fuzhou, Fujian province, 350014, China.
Chen M; Department of Medical Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, No.91, Fuma Road, Jin'an District, Fuzhou, Fujian province, 350014, China.
Li J; Laboratory of Immuno-Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, No.91, Fuma Road, Jin'an District, Fuzhou, Fujian province, 350014, China.
Huang C; Laboratory of Immuno-Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, No.91, Fuma Road, Jin'an District, Fuzhou, Fujian province, 350014, China.
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2024 Jan 05; Vol. 24 (1), pp. 39. Date of Electronic Publication: 2024 Jan 05.
Typ publikacji:
Journal Article
MeSH Terms:
Triple Negative Breast Neoplasms*/drug therapy
Hand-Foot Syndrome*
Hypertension*
Leukopenia*
Humans ; Clinical Protocols
Czasopismo naukowe
Tytuł:
A statistical method for removing unbalanced trials with multiple covariates in meta-analysis.
Autorzy:
Attanasio M; Dipartimento di Scienze Economiche, Aziendali e Statistiche, Università di Palermo, Palermo, Italy.
Aiello F; Facoltà di Scienze Economiche e Giuridiche, Università 'Kore' di Enna, Enna, Italy.
Tinè F; Azienda Sanitaria Universitaria Giuliano Isontina (ASI GI), Trieste, Italy.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Dec 15; Vol. 18 (12), pp. e0295332. Date of Electronic Publication: 2023 Dec 15 (Print Publication: 2023).
Typ publikacji:
Meta-Analysis; Journal Article
MeSH Terms:
Research Design*
Clinical Protocols ; Computer Simulation
Czasopismo naukowe
Tytuł:
Efficacy and safety of a pyrotinib-based regimen in non-small cell lung cancer patients harboring HER2 alterations: A real-world retrospective study.
Autorzy:
Wang X; Department of Medical Oncology, Qilu Hospital of Shandong University, Jinan, Shandong, China.
Wang J
Chu Y
Hao J
Pokaż więcej
Źródło:
Journal of cancer research and therapeutics [J Cancer Res Ther] 2023 Dec 01; Vol. 19 (6), pp. 1663-1668. Date of Electronic Publication: 2023 Dec 28.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Non-Small-Cell Lung*/genetics
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Breast Neoplasms*
Humans ; Female ; Retrospective Studies ; Clinical Protocols ; Receptor, ErbB-2/genetics
Czasopismo naukowe
Tytuł:
Study protocol for safety and efficacy of all-oral shortened regimens for multidrug-resistant tuberculosis: a multicenter randomized withdrawal trial and a single-arm trial [SEAL-MDR].
Autorzy:
Fu L; Division Two of Pulmonary Diseases Department, Shenzhen Third People's Hospital, Shenzhen Clinical Research Center for Tuberculosis, National Clinical Research Center for Infectious Disease (Shenzhen), Southern University of Science and Technology, 29 Bulan Rd, Longgang District, Shenzhen, 518112, China.
Xiong J; Health Science Center, Shenzhen University, 3688 Nanhai Avenue, Nanshan District, Shenzhen, 518060, China.
Wang H; Peking University Clinical Research Institute, Peking University First Hospital, Xueyuan Rd 38#, Haidian District, Beijing, 100000, 100191, China.
Zhang P; Division Two of Pulmonary Diseases Department, Shenzhen Third People's Hospital, Shenzhen Clinical Research Center for Tuberculosis, National Clinical Research Center for Infectious Disease (Shenzhen), Southern University of Science and Technology, 29 Bulan Rd, Longgang District, Shenzhen, 518112, China.
Yang Q; Division Two of Pulmonary Diseases Department, Shenzhen Third People's Hospital, Shenzhen Clinical Research Center for Tuberculosis, National Clinical Research Center for Infectious Disease (Shenzhen), Southern University of Science and Technology, 29 Bulan Rd, Longgang District, Shenzhen, 518112, China.
Cai Y; Department of Pathogen Biology, Guangdong Key Laboratory of Regional Immunity and Diseases, Shenzhen University School of Medicine, 1066 Xueyuan Ave, Nanshan District, Shenzhen, 518060, China.
Wang W; Division Two of Pulmonary Diseases Department, Shenzhen Third People's Hospital, Shenzhen Clinical Research Center for Tuberculosis, National Clinical Research Center for Infectious Disease (Shenzhen), Southern University of Science and Technology, 29 Bulan Rd, Longgang District, Shenzhen, 518112, China.; Department of Pathogen Biology, Guangdong Key Laboratory of Regional Immunity and Diseases, Shenzhen University School of Medicine, 1066 Xueyuan Ave, Nanshan District, Shenzhen, 518060, China.
Sun F; Department of Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, National Medical Center for Infectious Diseases, Huashan Hospital, Fudan University, 12 Urumqi Middle Road, Jing'an District, Shanghai, 200040, China.
Zhang X; Tuberculosis Prevention and Control Department, The Fourth People's Hospital of Foshan, 106 Jinlannan Rd, Chancheng District, Foshan, 528000, China.
Wang Z; Division Two of Pulmonary Diseases Department, Shenzhen Third People's Hospital, Shenzhen Clinical Research Center for Tuberculosis, National Clinical Research Center for Infectious Disease (Shenzhen), Southern University of Science and Technology, 29 Bulan Rd, Longgang District, Shenzhen, 518112, China.
Chen X; Department of Pathogen Biology, Guangdong Key Laboratory of Regional Immunity and Diseases, Shenzhen University School of Medicine, 1066 Xueyuan Ave, Nanshan District, Shenzhen, 518060, China. .
Zhang W; Department of Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, National Medical Center for Infectious Diseases, Huashan Hospital, Fudan University, 12 Urumqi Middle Road, Jing'an District, Shanghai, 200040, China. .
Deng G; Division Two of Pulmonary Diseases Department, Shenzhen Third People's Hospital, Shenzhen Clinical Research Center for Tuberculosis, National Clinical Research Center for Infectious Disease (Shenzhen), Southern University of Science and Technology, 29 Bulan Rd, Longgang District, Shenzhen, 518112, China. .
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2023 Nov 27; Vol. 23 (1), pp. 834. Date of Electronic Publication: 2023 Nov 27.
Typ publikacji:
Clinical Trial Protocol; Journal Article
MeSH Terms:
Extensively Drug-Resistant Tuberculosis*/drug therapy
Mycobacterium tuberculosis*
Tuberculosis, Multidrug-Resistant*/drug therapy
Humans ; Antitubercular Agents/adverse effects ; Clinical Protocols ; Randomized Controlled Trials as Topic ; Multicenter Studies as Topic
Czasopismo naukowe
Tytuł:
A qualitative narrative review of protocols for women's health on short-term medical missions in Latin America and the Caribbean.
Autorzy:
Dainton C; Grand River Hospital, 835 King St. West, Kitchener, ON N2G 1G3, Canada.; Michael G. DeGroote School of Medicine, McMaster University, 10-B Victoria Street South, 3rd Floor Kitchener, ON N2G 1C3, Canada.; Medical Service Trip, 1002-8 The Esplanade, Toronto, ON M5E0A6, Canada.
Chu CH; Medical Service Trip, 1002-8 The Esplanade, Toronto, ON M5E0A6, Canada.; Lawrence S. Bloomberg Faculty of Nursing, University of Toronto, 155 College St Suite 130, Toronto, ON M5T 1P8, Canada.; Toronto Rehabilitation Institute, University Health Network, Toronto, ON, Canada.
Pokaż więcej
Źródło:
International health [Int Health] 2022 Jul 01; Vol. 14 (4), pp. 434-441.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Clinical Protocols*
Medical Missions*
Female ; Humans ; Caribbean Region ; Latin America ; Women's Health
Czasopismo naukowe
Tytuł:
Effectiveness of the Unified Protocol for the transdiagnostic treatment of emotional disorders in online and group format in Argentina: study protocol for a randomized controlled trial.
Autorzy:
Celleri M; Facultad de Psicología, Universidad de Buenos Aires, Buenos Aires, Argentina. .
Cremades CF; Facultad de Psicología, Universidad de Buenos Aires, Buenos Aires, Argentina.
Etchevers MJ; Facultad de Psicología, Universidad de Buenos Aires, Buenos Aires, Argentina.
Garay CJ; Facultad de Psicología, Universidad de Buenos Aires, Buenos Aires, Argentina.
Pokaż więcej
Źródło:
Trials [Trials] 2023 Oct 19; Vol. 24 (1), pp. 678. Date of Electronic Publication: 2023 Oct 19.
Typ publikacji:
Clinical Trial Protocol; Journal Article
MeSH Terms:
Anxiety Disorders*/therapy
COVID-19*/therapy
Humans ; Quality of Life ; Argentina ; Clinical Protocols ; Treatment Outcome ; Randomized Controlled Trials as Topic
Czasopismo naukowe
Tytuł:
Corticosteroids in the treatment of IgA nephropathy: lessons from the TESTING trial.
Autorzy:
Zhang Y; Renal Division, Department of Medicine, Peking University First Hospital, Beijing, People's Republic of China.
Hu YT; Renal Division, Department of Medicine, Peking University First Hospital, Beijing, People's Republic of China.; Peking University Health Science Center, Xue Yuan Road 38, Beijing, 100191, People's Republic of China.
Lv JC; Renal Division, Department of Medicine, Peking University First Hospital, Beijing, People's Republic of China.
Zhang H; Renal Division, Department of Medicine, Peking University First Hospital, Beijing, People's Republic of China. .
Pokaż więcej
Źródło:
Pediatric nephrology (Berlin, Germany) [Pediatr Nephrol] 2023 Oct; Vol. 38 (10), pp. 3211-3220. Date of Electronic Publication: 2023 Mar 07.
Typ publikacji:
Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Glomerulonephritis, IGA*/diagnosis
Glomerulonephritis, IGA*/drug therapy
Young Adult ; Humans ; Child ; Adrenal Cortex Hormones/adverse effects ; Methylprednisolone/adverse effects ; Clinical Protocols ; Multicenter Studies as Topic
Czasopismo naukowe
Tytuł:
Multimodal non-invasive non-pharmacological therapies for chronic pain: mechanisms and progress.
Autorzy:
Shi Y; Department of Rehabilitation, Zhujiang Hospital, Southern Medical University, Guangzhou, 510282, China.
Wu W; Department of Rehabilitation, Zhujiang Hospital, Southern Medical University, Guangzhou, 510282, China. .
Pokaż więcej
Źródło:
BMC medicine [BMC Med] 2023 Sep 29; Vol. 21 (1), pp. 372. Date of Electronic Publication: 2023 Sep 29.
Typ publikacji:
Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Chronic Pain*/therapy
Humans ; Chronic Disease ; Combined Modality Therapy ; Clinical Protocols
Czasopismo naukowe
Tytuł:
Comparison of Four Treatment Protocols with Intra-Articular Medium Molecular Weight Hyaluronic Acid in Induced Temporomandibular Osteoarthritis: An Experimental Study.
Autorzy:
Wen S; Doctoral Program in Morphological Sciences, Faculty of Medicine, Universidad de La Frontera, Temuco 4780000, Chile.; Grupo de Investigación de Pregrado en Odontología, Facultad de Ciencias de la Salud (FACSA), Universidad Autónoma de Chile, Temuco 4810101, Chile.
Iturriaga V; Temporomandibular Disorder and Orofacial Pain Program, Department of Integral Adult Care Dentistry, Universidad de La Frontera, Temuco 4780000, Chile.; Sleep & Pain Research Group, Faculty of Dentistry, Universidad de La Frontera, Temuco 4780000, Chile.; Center of Excellence in Morphological and Surgical Studies (CEMyQ), Universidad de La Frontera, Temuco 4780000, Chile.
Vásquez B; Department of Basic Sciences, Faculty of Medicine, Universidad de La Frontera, Temuco 4780000, Chile.
Del Sol M; Doctoral Program in Morphological Sciences, Faculty of Medicine, Universidad de La Frontera, Temuco 4780000, Chile.; Center of Excellence in Morphological and Surgical Studies (CEMyQ), Universidad de La Frontera, Temuco 4780000, Chile.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Sep 15; Vol. 24 (18). Date of Electronic Publication: 2023 Sep 15.
Typ publikacji:
Journal Article
MeSH Terms:
Lagomorpha*
Osteoarthritis*/drug therapy
Animals ; Rabbits ; Hyaluronic Acid ; Molecular Weight ; Clinical Protocols
Czasopismo naukowe
Tytuł:
Can vitamin B6 alleviate the adverse reactions of quadruple anti-Helicobacter pylori regimen? : randomized controlled trial.
Autorzy:
Cui MY; Shanghai Key Laboratory of Pancreatic Disease, Shanghai Jiao Tong University School of Medicine, Shanghai, 201620, China.; Department of Gastroenterology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 201620, China.
Zhang MJ; Department of Gastroenterology, Anhui Provincial Key Laboratory of Digestive Disease, The First Affiliated Hospital of Anhui Medical University, Hefei, 230032, China.
Jiang QL; Department of Gastroenterology, Jiading branch of Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, 800 Huangjiahuayuan Road, Shanghai, 201803, China.
Pei ZM; Department of Gastroenterology, Jiading branch of Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, 800 Huangjiahuayuan Road, Shanghai, 201803, China.
Cui ZY; Department of Gastroenterology, Jiading branch of Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, 800 Huangjiahuayuan Road, Shanghai, 201803, China.
Kang M; Clinical Research Center, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200080, China.
Lu LG; Department of Gastroenterology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 201620, China.
Lu YY; Department of Gastroenterology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 201620, China. .; Department of Gastroenterology, Jiading branch of Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, 800 Huangjiahuayuan Road, Shanghai, 201803, China. .
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2023 Sep 11; Vol. 23 (1), pp. 590. Date of Electronic Publication: 2023 Sep 11.
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
Vitamin B 6*/therapeutic use
Helicobacter pylori*
Humans ; Metronidazole/adverse effects ; Minocycline ; Clinical Protocols ; Vitamins
Czasopismo naukowe
Tytuł:
Clinical protocol: Feasibility of evaluating abemaciclib neuropharmacokinetics of diffuse midline glioma using intratumoral microdialysis.
Autorzy:
Nduom EK; Department of Neurosurgery, Emory University School of Medicine, Atlanta, GA, United States of America.
Glod J; Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States of America.
Brown DA; Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, United States of America.
Fagan M; Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States of America.
Dalmage M; Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, United States of America.
Heiss J; Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, United States of America.
Steinberg SM; Biostatistics and Data Management Section, Office of the Clinical Director, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States of America.
Peer C; Clinical Pharmacology, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States of America.
Figg WD; Clinical Pharmacology, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States of America.
Jackson S; Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States of America.; Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Sep 08; Vol. 18 (9), pp. e0291068. Date of Electronic Publication: 2023 Sep 08 (Print Publication: 2023).
Typ publikacji:
Clinical Trial; Journal Article; Research Support, N.I.H., Intramural
MeSH Terms:
Dialysis Solutions*
Glioma*/drug therapy
Young Adult ; Humans ; Feasibility Studies ; Microdialysis ; Clinical Protocols
Czasopismo naukowe
Tytuł:
Enhanced Recovery After Surgery (ERAS) protocols following emergency intra-abdominal surgery: A systematic review and meta-analysis protocol.
Autorzy:
McKechnie T; Division of General Surgery, Department of Surgery, McMaster University, Hamilton, Ontario, Canada.; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.
Parpia S; Division of Orthopedic Surgery, Department of Surgery, McMaster University, Hamilton, Ontario, Canada.
Bhandari M; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.; Division of Orthopedic Surgery, Department of Surgery, McMaster University, Hamilton, Ontario, Canada.
Dionne JC; Division of Orthopedic Surgery, Department of Surgery, McMaster University, Hamilton, Ontario, Canada.
Eskicioglu C; Division of General Surgery, Department of Surgery, McMaster University, Hamilton, Ontario, Canada.; Division of General Surgery, Department of Surgery, St. Joseph Healthcare, Hamilton, Ontario, Canada.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Sep 08; Vol. 18 (9), pp. e0291140. Date of Electronic Publication: 2023 Sep 08 (Print Publication: 2023).
Typ publikacji:
Journal Article
MeSH Terms:
Abdominal Cavity*
Enhanced Recovery After Surgery*
Adult ; Humans ; Elective Surgical Procedures ; Meta-Analysis as Topic ; Perioperative Care ; Randomized Controlled Trials as Topic ; Systematic Reviews as Topic ; Clinical Protocols
Czasopismo naukowe
Tytuł:
Does the Academy of Breastfeeding Medicine's Clinical Protocol #36 'The Mastitis Spectrum' promote overtreatment and risk worsened outcomes for breastfeeding families? Commentary.
Autorzy:
Douglas P; The School of Nursing and Midwifery, Griffith University, Brisbane, Australia. .; General Practice Clinical Unit, The University of Queensland, Brisbane, Australia. .; Medical Director, The NDC Institute, ndcinstitute.com.au, Brisbane, Australia. .
Pokaż więcej
Źródło:
International breastfeeding journal [Int Breastfeed J] 2023 Sep 05; Vol. 18 (1), pp. 51. Date of Electronic Publication: 2023 Sep 05.
Typ publikacji:
Journal Article; Review; Comment
MeSH Terms:
Breast Feeding*
Mastitis*
Infant ; Humans ; Female ; Lactation ; Inflammation ; Overtreatment ; Clinical Protocols
Czasopismo naukowe
Tytuł:
Bonding performance of glass ionomer cement to carious dentin treated with different surface treatment protocols using silver diamine fluoride.
Autorzy:
Rinsathon J; Dental department, Phon Hospital, Khon Kaen, Thailand.
Wiriyasuebpong S; Department of Restorative Dentistry, Faculty of Dentistry, Khon Kaen University, Khon Kaen, Thailand.
Thariya K; Department of Restorative Dentistry, Faculty of Dentistry, Khon Kaen University, Khon Kaen, Thailand.
Jiradechochai P; Department of Restorative Dentistry, Faculty of Dentistry, Khon Kaen University, Khon Kaen, Thailand.
Phetsuk P; Research Unit, Faculty of Dentistry, Khon Kaen University, Khon Kaen, Thailand.
Bouanil S; Research Unit, Faculty of Dentistry, Khon Kaen University, Khon Kaen, Thailand.
Saikaew P; Department of Operative Dentistry and Endodontics, Faculty of Dentistry, Mahidol University, Bangkok, Thailand.
Pawaputanon Na Mahasarakham C; Department of Restorative Dentistry, Faculty of Dentistry, Khon Kaen University, Khon Kaen, Thailand. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Aug 30; Vol. 13 (1), pp. 14233. Date of Electronic Publication: 2023 Aug 30.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Glass Ionomer Cements*/therapeutic use
Silver Compounds*/therapeutic use
Humans ; Clinical Protocols ; Analysis of Variance
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies